Method Article

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

737 views

DOI:

10.3791/68617

October 7th, 2025

In This Article

Summary

The protocol describes a tandem immunofluorescence hybridization assay with formalin-fixed paraffin-embedded tissue to detect and quantify microRNA and multiplexed proteins simultaneously.

Abstract

When using traditional probe-based in situ hybridization (ISH) imaging detection methods, microRNAs (miRNAs) are difficult to capture due to their size, which ranges from 19 to 25 nucleotides. However, as miRNAs are key epigenetic regulators that contribute to normal physiology and numerous pathological conditions, understanding the spatiotemporal behavior of miRNAs is important to unravel their function at the cellular and subcellular levels. This creates a clear need for adequate detection and visualization techniques. Therefore, we created MicroRNA Amplification and Recognition through Locked-nucleic-acid in situ hybridizatioN (MARLIN), which was developed and optimized utilizing multiplex immunofluorescence staining, and locked nucleic acid (LNA) probes targeted to a miRNA. This method can quantify miRNA with multiplexed protein expression, which allows the quantification of intracellular and extracellular miRNA within the tumor microenvironment (TME) with high sensitivity and reproducibility. The combined use of miRNA detection and protein capture assays can also provide a comprehensive understanding of cellular functions and regulatory mechanisms within that TME.

Introduction

microRNAs
Although microRNAs (miRNA) are incredibly small, ranging 19-25 nucleotides in length, these single-stranded RNA molecules are potent regulators in gene expression, modulating messenger RNAs (mRNAs) post-transcriptionally through sequence-specific interactions1. In essence, miRNAs act as negative regulators by binding to target mRNAs, either preventing their translation or promoting their degradation through mRNA cleavage, depending on the degree of complementarity, which ultimately leads to decreased protein output from the targeted gene. While miRNAs are basically non-coding RNA, approximately 40% of all miRNAs....

Access restricted. Please log in or start a trial to view this content.

Protocol

This protocol uses formalin-fixed paraffin-embedded (FFPE) tissues of human ovarian tumor tissue sections from patients with HGSC. These samples were collected from previously untreated patients undergoing primary cytoreductive surgery for ovarian cancer. All samples and clinical data were obtained from the ovarian cancer repository of the Department of Gynecologic Oncology and Reproductive Medicine under protocols approved by the University of Texas MD Anderson's Institutional Review Board. Written informed consent from the patients was obtained by front desk personnel, and the studies were conducted in accordance with recognized ethical guidelines.

Access restricted. Please log in or start a trial to view this content.

Results

When testing this protocol, it is important to have two serial sections of the same representative sample for accuracy and comparison. In this case, a High-Grade Ovarian Cancer (HGSC) sample was used to compare the results. A control slide (Figure 2A-B) that would only go through the miRNA staining and a test slide that would undergo both protein and miRNA staining (Figure 2C-J) were used.

Access restricted. Please log in or start a trial to view this content.

Discussion

Though the importance of miRNAs is recognized and understood, observations of both normal development and disease states are currently hindered by the difficulty of studying miRNAs using standard methods. The scarcity of in situ methods led to the development of MARLIN (miRNA FISH assay). Given the homology and short length of miRNAs, it becomes a challenge to visualize their location and effect on post-transcriptomic regulation. This protocol development utilizes Locked Nucleic Acid Probes (LNA). LNAs are modif.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We would like to acknowledge the following people, Chi Lam Au Yeung and Manjunath Nimmakayalu, who were a part of Basant's thesis committee while the assay was in development. Also, Samuel Mok, who sectioned and provided the samples used. Lastly, we acknowledge Johan Doré and Dan Winkowski, who provided extensive assistance during analysis and the use of the Visiopharm software. This research was funded in part by the Ovarian Cancer Research Alliance (OCRA 811621 and 891490), the Sie Foundation, and the Stephanie C. Stelter Endowment Fund. This research was performed in collaboration with the Flow Cytometry and Cellular Imaging Core Facility, which is support....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
10x TRIS-buffered Saline (TBS) pH 7.6 Thermo Fisher Scientific J62662 K7For intermittent washes between steps
1x Opal Antibody Diluent/Block Akoya BiosciencesARD1001EAProtein blocking solution
1x Plus Automation Amplification DiluentAkoya Biosciences FP1609Used to dilute Opal fluorophores
20x Concentrate Saline Sodium Citrate (SSC) BufferSigma-AldrichS6639-1LFor miRNA washes after probe hybridization
4',6-diamidino-2-phenylindole (DAPI) Thermo Fisher Scientific/ InvitrogenEN62248 / 62248For nuclear staining
ACD HybEZ II Hybridization SystemACD Biotechne321711Oven used to regulate temperature during miRNAscope protocol
Anti-CD8 (D8A8Y), Rabbit mAbCell Signaling Technologies85336SExample of primary antibody used to optimize this protocol
Anti-Digoxigenin (Mouse) HRP ConjugateRevvity Health Sciences IncNEF832001EASecondary reagent used for miRNA detection
Anti-EpCAM (E6V8Y), Rabbit mAbCell Signaling Technologies93790Example of primary antibody used to optimize this protocol
Blocking Reagent PowderAkoya Biosciences FP1012miRNA blocking solution
Ethyl Alcohol 100% (200 Proof)Pharmco111000200For deparaffinization
EZ-AR1 BufferBioGeneXHK521-XAKUsed for antigen retrieval of FFPE tissue sections at the protein step
EZ-AR1 Elegance BufferBioGeneXHK546-XAKUsed for antigen retrieval of FFPE tissue sections at the miRNA probe step
EZ-Retriever IR SystemBioGeneXMW015-IRMicrowave used for antigen retrieval of FFPE tissue sections
Hydrogen Peroxide Solution 30% Sigma-Aldrich HX0640-5 For Tissue preparation. Helps to block endogenous peroxidase activity and to yield highly colored products
miR-181c-3p miRNA ProbeQiagen339112Example of miRNA probe used to optimize this protocol
miRCURY LNA miRNA ISH Buffer Set (FFPE)Qiagen339450 Used to dilute miRNA probe
Opal 620Akoya Biosciences FP1495001KTFluorophore to identify primary antibody
Opal 690 Akoya Biosciences FP1497001KTFluorophore to identify primary antibody
Opal Anti-Ms + Rb HRPAkoya BiosciencesARH1001EASecondary antibody used as a detection agent
Pierce 16% Formaldehyde (w/v), Methanol-freeThermo Fisher Scientific28908To make 3.7% PFA for tissue preparation
ProLong Diamond AntifadeThermo Fisher ScientificP36970Mounting media
RNAscope Protease PlusACD Biotechne322331To permeabilize tissue sections by partially digesting proteins & expose target miRNA molecules
RNAse-free water Corning 46-000-CM To clean and prep all equipment, and to use as a dilutant when necessary  
Tween 20Sigma-AldrichP1379-25MLTo make TBS-T
Tyramide Signal Amplification Plus Cyanine 3Akoya Biosciences NEL744001KTFluorophore to identify miRNA
U6 and Scramble miRNA ProbesQiagen339459Optional control probes
Xylenes Histological GradeThermo Fisher ScientificUN1307For deparaffinization

References

  1. Smolarz, B., Nowak, A. Z., Romanowicz, H. Breast cancer-epidemiology, classification, pathogenesis and treatment (review of literature). Cancers. 14 (10), 2569(2022).
  2. Davis-Dusenbery, B. N., Hata, A. Microrna in cancer: The involvem....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

MicroRNA DetectionMultiplex ImmunofluorescenceTumor MicroenvironmentProtein ColocalizationFFPE TissueTyramide Signal AmplificationSpatial TranscriptomicsEpCAM Antibody

Related Articles